This antibody is purified through a protein A column, followed by peptide affinity purification.
Immunogène
This PTPRCAP antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 90-118 amino acids from the Central region of human PTPRCAP.
PTPRCAP
Reactivité: Humain
WB, EIA
Hôte: Lapin
Polyclonal
unconjugated
Indications d'application
For WB starting dilution is: 1:1000
Restrictions
For Research Use only
Format
Liquid
Concentration
0.48 mg/mL
Buffer
Supplied in PBS with 0.09 % (W/V) sodium azide.
Agent conservateur
Sodium azide
Précaution d'utilisation
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock
4 °C,-20 °C
Stockage commentaire
Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Antigène
PTPRCAP
(Protein tyrosine Phosphatase, Receptor Type, C Polypeptide-Associated Protein (PTPRCAP))
anticorps AI605264, anticorps CD-45-AP, anticorps LPAP, anticorps LSM-1, anticorps CD45-AP, anticorps protein tyrosine phosphatase, receptor type, C polypeptide-associated protein, anticorps protein tyrosine phosphatase, receptor type C associated protein, anticorps protein tyrosine phosphatase, receptor type, C-associated protein, anticorps Ptprcap, anticorps PTPRCAP
Sujet
The protein encoded by this gene was identified as a transmembrane phosphoprotein specifically associated with tyrosine phosphatase PTPRC/CD45, a key regulator of T- and B-lymphocyte activation. The interaction with PTPRC may be required for the stable expression of this protein.